SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immucor

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mason Barge who wrote (97)7/8/1998 9:36:00 PM
From: Thomas Kirwin  Read Replies (1) of 422
 
Insider Ownership

Mason,

The 10-K filed by Immucor in August '97 indicates the following
insider ownership which includes options granted to management.

www4.edgar-online.com

Item 12.-Security Ownership of Certain Beneficial Owners and Management.

The following table sets forth as of August 15, 1997, the number
of shares of Common Stock of Immucor beneficially owned by each
director of the Company, and by each person known to the Company
to own more than 5% of the outstanding shares of Common Stock, and by
all of the executive officers and directors of the Company as a group.

Name of Beneficial Owner
(and address for those Shares Percent
owning more than five percent) Owned(1) of Class(1)

Edward L. Gallup 231,357(2) 2.8%

Ralph A. Eatz 307,526(2) 3.8%

Richard J. Still 159,250(2) 1.9%

Dr. Gioacchino De Chirico 37,500(3) *

Didier L. Lanson 8,750(4) *

Daniel T. McKeithan 53,778(4) *

G. Bruce Papesh 500(5) *

Kenneth B. Dart
P.O. Box 31300-SMB
Grand Cayman,
Cayman Islands, BWI 472,675(6) 5.9%

All directors and executive officers
as a group (seven persons) 798,661 8.9%

* less than 1%.

(1) Except as otherwise noted herein, percentages are determined on
the basis of 8,078,737 shares of Common Stock issued and outstanding
plus securities deemed outstanding pursuant to Rule 13-3(d)(1) of the
Securities Exchange Act of 1934, as amended. As a result, the
percentage of shares of Common Stock is calculated assuming that the
beneficial owner has exercised any options held by such beneficial
owner that are currently exercisable, or exercisable within 60 days of
August 15, 1997, and that no other options have been exercised by
anyone else. Unless otherwise indicated, the Company believes the
beneficial owner has sole voting and investment power over such
shares.

(2) Includes for each person an option to acquire 89,250 shares at an
exercise price of $9.33 and an option to acquire 30,000 shares at an
exercise price of $6.00.

(3) Includes a currently exercisable option to acquire 7,500 shares
of Common Stock at an exercise price of $6.00 and an option to
acquire 30,000 shares of Common Stock at an exercise price of $6.00.

(4) Includes a currently exercisable option to acquire 3,750 shares
at $5.40 per share and a currently exercisable option to acquire 5,000
shares at $6.00 per share.

(5) Includes 400 shares over which Mr. Papesh shares investment power
in his role as an investment advisor.

(6) Pursuant to SEC Form 13D/A filed on December 19, 1996 (filed on
May 15, 1997 electronically), 236,338 shares (2.93%) were owned by
Kenneth B. Dart, P.O. Box 31300-SMB, Grand Cayman, Cayman Islands,
BWI, and 236,337 shares (2.93%) were owned by Robert C. Dart, c/o Dart
Management Limited, P.O. Box 31363-SMB, Grand Cayman, Cayman Islands,
BWI. All such shares (472,675 total, or 5.9%) are deemed under common
control of Kenneth B. Dart as a result of an oral understanding by and
between Kenneth B. Dart and Robert C. Dart.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext